Please enable JS

DISCOVER

Managed Access Programmes

Our technological innovation platform called “CleanWeb-MAP” (CleanWeb Managed Access Programme) facilitates access to new drugs by eligible patients.

There are multiple terms that fall under the umbrella of MAP, including Compassionate Use, Early Access, Named Patient Use and Individual Patient Request Programmes to name but a few. The terms used may vary from country to country depending on local laws and regulations. Our module is closely linked to our CleanWeb software platform for medical data collection, it enables self-registration of prescribing physicians and pharmacists, for each new product related to MAP.

corner top

Ethical and compliant
mechanism of access to drugs

• MAPs provide alternative treatments to patients with life-threatening diseases with no therapeutic options
• CleanWeb-MAP meets local laws and regulations Seamless Managed Access Programmes

corner bottom

Entrust your project
to our expert
data management team

corner top

Drug use outcome
in a real-world setting

Allows you to gain valuable early experience with a product

CleanWeb-MAP facilitates the management of MAPs in real-life conditions

corner bottom

CleanWeb-MAP:
streamlined interactions with stakeholders

Each role and access are clearly defined Physicians, Nurses, Medical Advisor, Programme Manager, Pharmacovigilance officer, Logistics perfectly interact in the MAP cycle process.
The ordering process and the availability of drugs are assured in interaction with any external system and data source.
CleanWeb-MAP allows for the involvement of other stakeholders and for the integration of many additional behaviours (e.g., Pharmacist).

Download our Flyer on MAPs

Do you want to learn more about our e-health solution?
Just fill in the form and we will get back to you shortly

A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT

64 +

countries
involved

20 000 +

investigational
Centres

3 million +

patients
in database

50 000 +

users
worlwide

telemedicine technologies earth

LATEST NEWSOUR NEWS >

telemedecine technologies news

DMEA 2024 – Berlin

March 29, 2024

April 10 & 11, 2024 Telemedicine Technologies and OVHcloud are partnering to host health data collected in hospitals for medical research studies using the CleanWeb™ software suite. This collaboration allows Telemedicine Technologies to benefit from OVHcloud’s support, including 24/7 assistance and guarantees such as data localisation in France and transparency in data processing practices. DMEA […]

READ MORE
telemedecine technologies news

Improving Diversity in Clinical Trials

March 29, 2024

Applied Clinical Trials Online A lack of diversity in clinical trials is a critical issue, as racial and ethnic subgroups may respond differently to therapies, potentially undermining efficacy and safety outcomes and producing results that are not representative of the patients who will receive the treatment in the real world. Furthermore, clinical trials provide access […]

READ MORE
telemedecine technologies news

Innovation package: METAglut1 is reimbursed under common law

March 29, 2024

Mind health The startup Metafora Biosystems, which develops a platform for cellular metabolism analysis, announced on March 11th the reimbursement approval in France for its METAglut1 test, aiding in the diagnosis of Glut1 transporter deficiency syndrome since February 15th. This blood-based test is less invasive than the previously preferred lumbar puncture. It’s the first healthcare […]

READ MORE